Viridian Therapeutics, Inc.\DE (VRDN) Operating Margin (2016 - 2025)
Historic Operating Margin for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to 56.7%.
- Viridian Therapeutics, Inc.\DE's Operating Margin rose 970130700.0% to 56.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 463.52%, marking a year-over-year increase of 932590000.0%. This contributed to the annual value of 99018.21% for FY2024, which is 179831800.0% down from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its Operating Margin stood at 56.7% for Q3 2025, which was up 970130700.0% from 142356.0% recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Operating Margin ranged from a high of 56.7% in Q3 2025 and a low of 142356.0% during Q2 2025
- In the last 5 years, Viridian Therapeutics, Inc.\DE's Operating Margin had a median value of 71144.44% in 2023 and averaged 57473.73%.
- Its Operating Margin has fluctuated over the past 5 years, first crashed by -707779500bps in 2023, then skyrocketed by 970130700bps in 2025.
- Quarter analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Operating Margin stood at 13589.25% in 2021, then tumbled by -244bps to 46729.52% in 2022, then plummeted by -112bps to 99275.0% in 2023, then decreased by -22bps to 121488.89% in 2024, then soared by 100bps to 56.7% in 2025.
- Its Operating Margin was 56.7% in Q3 2025, compared to 142356.0% in Q2 2025 and 130369.44% in Q1 2025.